Secondary hyperparathyroidism and renal osteodystrophy in chronic renal failure. Analysis of 195 patients, with observations on the effects of chronic dialysis, kidney transplantation and subtotal parathyroidectomy.

PubWeight™: 1.61‹?› | Rank: Top 4%

🔗 View Article (PMID 4909606)

Published in Medicine (Baltimore) on September 01, 1969

Authors

A I Katz, C L Hampers, J P Merrill

Articles citing this

Subtotal parathyroidectomy in chronic renal failure: a seven-year experience in a dialysis and transplant program. Ann Surg (1971) 1.83

Effect of parathyroid hormone on rat heart cells. J Clin Invest (1981) 1.50

Acute pancreatitis and hyperamylasemia in renal homograft recipients. Arch Surg (1972) 1.24

Extraosseous calcification. Evidence for abnormal pyrophosphate metabolism in uremia. J Clin Invest (1976) 1.21

Effect of parathyroid hormone on erythropoiesis. J Clin Invest (1981) 1.18

Aseptic necrosis in the femur after renal transplantation. Ann Surg (1972) 0.91

Quantitative skeletal histology in untreated end-stage renal failure. Br Med J (1973) 0.90

Effect of thyroparathyroidectomy and parathyroidectomy on renal function and the nephrotic syndrome in rat nephrotoxic serum nephritis. J Clin Invest (1981) 0.87

Mitral annular calcification and brown tumor of the rib in a child with chronic renal failure. Pediatr Nephrol (2005) 0.86

Calcinosis of joints and periarticular tissues associated with vitamin D intoxication. Ann Rheum Dis (1985) 0.85

Therapeutic effect of cimetidine in patients undergoing haemodialysis. Br Med J (1979) 0.85

Damage Control Orthopedics Management as Vital Procedure in Elderly Patients with Femoral Neck Fractures Complicated with Chronic Renal Failure: A Retrospective Cohort Study. PLoS One (2016) 0.84

The effects in the rat of varying intakes of dietary calcium, phosphorus, and hydrogen ion on hyperparathyroidism due to chronic renal failure. J Clin Invest (1974) 0.83

Ischaemic myocardial damage in chronic renal failure. Br Med J (1971) 0.83

Calciphylaxis: etiology of progressive vascular calcification and gangrene? Ann Surg (1973) 0.83

The arthropathy of maintenance intermittent peritoneal dialysis. Can Med Assoc J (1980) 0.82

The high prevalence of chronic kidney disease-mineral bone disorders: A hospital-based cross-sectional study. Indian J Nephrol (2012) 0.81

Erythrocyte survival in chronic renal failure. Role of secondary hyperparathyroidism. J Clin Invest (1985) 0.80

Targets for parathyroid hormone in secondary hyperparathyroidism: is a "one-size-fits-all" approach appropriate? A prospective incident cohort study. BMC Nephrol (2014) 0.80

The pathophysiology and clinical aspects of hypercalcemic disorders. West J Med (1978) 0.78

Effects of haemodialysis on bone in chronic renal failure. Br Med J (1972) 0.77

A microradiographic study of bone disease in uremia. Trans Am Clin Climatol Assoc (1971) 0.75

Articles by these authors

Five years' experience in renal transplantation with immunosuppressive drugs: survival, function, complications, and the role of lymphocyte depletion by thoracic duct fistula. Ann Surg (1968) 3.34

Immunologic rejection of human cancer transplanted with a renal allograft. N Engl J Med (1968) 2.70

Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am J Med (1970) 2.43

Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation. N Engl J Med (1972) 2.33

Intrarenal distribution of blood flow in the transplanted dog kidney: effect of denervation and rejection. J Clin Invest (1967) 2.14

Megaloblastic hematopoiesis in uremia and in patients on long-term hemodialysis. N Engl J Med (1967) 2.06

Alteration of the cytotoxic action of sensitized lymphocytes by cholinergic agents and activators of adenylate cyclase. Proc Natl Acad Sci U S A (1972) 2.01

The modulating influence of cyclic nucleotides upon lymphocyte-mediated cytotoxicity. J Exp Med (1973) 1.92

The success of medicare's end-stage renal-disease program: the case for profits and the private marketplace. N Engl J Med (1981) 1.88

Subtotal parathyroidectomy in chronic renal failure: a seven-year experience in a dialysis and transplant program. Ann Surg (1971) 1.83

Urine fibrinogen fragments in human renal allografts. A possible mechanism of renal injury. N Engl J Med (1968) 1.80

Survival of patients undergoing chronic hemodialysis and renal transplantation. N Engl J Med (1973) 1.74

IgA nephropathy: morphologic predictors of progressive renal disease. Hum Pathol (1982) 1.73

Human renal isografts: a clinical and pathologic analysis. Medicine (Baltimore) (1968) 1.63

Coagulation studies in the hyperacute and other forms of renal-allograft rejection. N Engl J Med (1969) 1.62

The role of sodium-potassium-activated adenosine triphosphatase in the reabsorption of sodium by the kidney. J Clin Invest (1967) 1.62

Physiologic role of sodium-potassium-activated adenosine triphosphatase in the transport of cations across biologic membranes. N Engl J Med (1968) 1.61

Metabolism of proinsulin, insulin, and C-peptide in the rat. J Clin Invest (1973) 1.60

Dopamine-induced endocytosis of Na+,K+-ATPase is initiated by phosphorylation of Ser-18 in the rat alpha subunit and Is responsible for the decreased activity in epithelial cells. J Biol Chem (1999) 1.59

Renal transplantation in the inbred rat. 3. A study of heterologous anti-thymocyte sera. J Exp Med (1967) 1.57

Glomerulonephritis (third of three parts). N Engl J Med (1974) 1.52

Factors contributing to the declining mortality rate in renal transplantation. N Engl J Med (1978) 1.45

Pregnancy in women with kidney disease. Kidney Int (1980) 1.44

Senescence and the renal vasculature in normal man. Circ Res (1974) 1.43

Alterations in human serum beta-1C-gobulin (C'3) in renal transplantation. Am J Med (1967) 1.42

Thyroid hormone and the kidney. Nephron (1975) 1.41

Intravascular coagulation (IVC) in human renal allograft rejection. Transplant Proc (1969) 1.39

Hypertension in pregnancy. N Engl J Med (1985) 1.39

Phosphoinositide-3 kinase binds to a proline-rich motif in the Na+, K+-ATPase alpha subunit and regulates its trafficking. Proc Natl Acad Sci U S A (2000) 1.38

Thyroid dysfunction in chronic renal failure. A study of the pituitary-thyroid axis and peripheral turnover kinetics of thyroxine and triiodothyronine. J Clin Invest (1977) 1.36

Isoproterenol increases Na+-K+-ATPase activity by membrane insertion of alpha-subunits in lung alveolar cells. Am J Physiol (1999) 1.35

Na-K-ATPase activity along the rabbit, rat, and mouse nephron. Am J Physiol (1979) 1.35

Phosphorylation of the catalyic alpha-subunit constitutes a triggering signal for Na+,K+-ATPase endocytosis. J Biol Chem (1998) 1.34

Simplified hippuran clearance. Measurement of renal function in man with simplified hippuran clearances. Nephron (1966) 1.33

Receptor-mediated inhibition of renal Na(+)-K(+)-ATPase is associated with endocytosis of its alpha- and beta-subunits. Am J Physiol (1997) 1.31

Lupus nephropathy without clinical renal involvement. Medicine (Baltimore) (1977) 1.30

Effect of chronic renal failure and hemodialysis on carbohydrate metabolism. J Clin Invest (1966) 1.30

Recovery from prolonged renal failure in patients with accelerated hypertension. N Engl J Med (1974) 1.29

Acute oliguric renal failure in man: evidence for preferential renal cortical ischemia. Medicine (Baltimore) (1968) 1.28

Distinct pathways for basolateral targeting of membrane and secretory proteins in polarized epithelial cells. Proc Natl Acad Sci U S A (1991) 1.27

Actions of hormones on the kidney. Annu Rev Physiol (1977) 1.27

Angiotensin II binding sites in individual segments of the rat nephron. J Clin Invest (1986) 1.26

Determination of Na-K-ATPase activity in single segments of the mammalian nephron. Am J Physiol (1979) 1.25

Sodium- and potassium-activated adenosine triphosphatase of gills: role in adaptation of teleosts to salt water. Science (1967) 1.24

Renal transplantation in the inbred rat. I. Morphologic, immunologic, and functional alterations during acute rejection. Transplantation (1967) 1.22

Kidney function in the pregnant rat. J Lab Clin Med (1971) 1.22

Sauna baths in the treatment of chronic renal failure. Trans Am Soc Artif Intern Organs (1966) 1.22

Renal sodium- and potassium-activated adenosine triphosphatase and sodium reabsorption in the hypothyroid rat. J Clin Invest (1973) 1.21

Mechanics of distension of dog veins and other very thin-walled tubular structures. Circ Res (1970) 1.20

Editoral: Cardiovascular disease in dialysis patients. N Engl J Med (1974) 1.20

Uremic pericarditis. Clinical features and management. Circulation (1968) 1.20

Human renal allografts. Interpretation of morphologic and immunohistochemical observations. Am J Pathol (1968) 1.19

Relation of glomerular filtration rate and sodium reabsorption to kidney size in compensatory renal hypertrophy. Yale J Biol Med (1967) 1.18

An immunosupressive site of action of heterologous antilymphocyte serum. Lancet (1967) 1.17

Short-term regulation of renal Na-K-ATPase activity: physiological relevance and cellular mechanisms. Am J Physiol (1993) 1.15

Liver disease in kidney transplant patients receiving azathioprine. Arch Intern Med (1973) 1.15

Renal transplantation in the inbred rat. II. An immunohistochemical study of acute allograft rejection. Am J Pathol (1968) 1.14

Disappearance of "uremic" itching after subtotal parathyroidectomy. N Engl J Med (1968) 1.13

Effect of sodium balance on intrarenal distribution of blood flow in normal man. J Appl Physiol (1970) 1.13

Independence of onset of compensatory kidney growth from changes in renal function. Am J Physiol (1976) 1.13

Differential expression of Na-K-ATPase isoforms in rat alveolar epithelial cells. Am J Physiol (1997) 1.12

Cellular immunity in the mouse. II. Correlation of in vivo and in vitro phenomena. Cell Immunol (1972) 1.12

Hepatitis affecting hemodialysis and transplant patients. Its considerations and consequences. Arch Intern Med (1973) 1.11

Vestibular toxicity of gentamicin. Incidence in patients receiving long-term hemodialysis therapy. Arch Intern Med (1978) 1.10

Cellular immunity in the mouse. I. In vitro lymphocyte reactivity. Cell Immunol (1972) 1.10

Diffusion of glucose, insulin, inulin, and Evans blue protein into thoracic duct lymph of man. J Clin Invest (1967) 1.10

Heterogeneity of plasma glucagon: patterns in patients with chronic renal failure and diabetes. J Clin Endocrinol Metab (1976) 1.10

Effect of total parathyroidectomy and uremia on the chemical composition of bone, skin and aorta in the rat. Isr J Med Sci (1971) 1.09

Glomerulonephritis in renal transplants. Transplant Proc (1969) 1.09

Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure. J Clin Invest (1976) 1.08

Complement metabolism in man: hypercatabolism of the fourth (C4) and third (C3) components in patients with renal allograft rejection and hereditary, angioedema (HAE). J Clin Invest (1969) 1.08

Cholinergic augmentation of lymphocyte-mediated cytotoxicity. A study of the cholinergic receptor of cytotoxic T lymphocytes. Proc Natl Acad Sci U S A (1974) 1.07

Avascular necrosis of the femoral head in patients on chronic hemodialysis. Trans Am Soc Artif Intern Organs (1972) 1.06

Course of renal pathology in patients with systemic lupus erythematosus. Am J Med (1984) 1.06

G protein-coupled receptors regulate Na+,K+-ATPase activity and endocytosis by modulating the recruitment of adaptor protein 2 and clathrin. Proc Natl Acad Sci U S A (2000) 1.05

Microtubule function in immune and nonimmune lymphocyte-mediated cytotoxicity. Science (1973) 1.05

Diagnosis and management of rejection in allografted kidneys. Transplant Proc (1971) 1.05

Peripheral plasma renin activity in renal-homotransplant recipients. N Engl J Med (1966) 1.04

The role of vasoconstriction in the ischemia of renal allograft rejection. Transplantation (1968) 1.04

Hemorrhagic pleural effusion in patients undergoing chronic hemodialysis. Ann Intern Med (1975) 1.03

Nondiabetic renal disease in patients with diabetes mellitus. Am J Med (1983) 1.03

Hypertension in chronic renal failure. Treatment with hemodialysis and nephrectomy. Arch Intern Med (1974) 1.03

Renal vascular responses to angiotensin and norepinephrine in normal man. Effect of sodium intake. Circ Res (1972) 1.02

Hypercalcaemia after oral calcium-carbonate therapy in patients on chronic haemodialysis. Lancet (1973) 1.02

Modulation of renal sodium-potassium-adenosine triphosphatase by aldosterone. Effect of high physiologic levels on enzyme activity in isolated rat and rabbit tubules. J Clin Invest (1985) 1.02

Acute renal failure due to nephrotoxins. N Engl J Med (1970) 1.02

Variations in motor nerve conduction velocity in normal and uremic patients. Arch Intern Med (1971) 1.01